{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T10:20:58Z","timestamp":1777717258989,"version":"3.51.4"},"reference-count":43,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100012399","name":"Biomedical Advanced Research and Development Authority","doi-asserted-by":"crossref","award":["Contract HHSO100201000059C"],"award-info":[{"award-number":["Contract HHSO100201000059C"]}],"id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J Toxicol"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:p>A recombinant protective antigen (rPA) anthrax vaccine candidate (rPA7909) was developed as a next-generation vaccine indicated for postexposure prophylaxis of disease resulting from suspected or confirmed Bacillus anthracis exposure. The lyophilized form of rPA7909-vaccinated candidate contains 75 \u00b5g purified rPA, 750 \u00b5g aluminum (as Alhydrogel adjuvant), and 250 \u00b5g of an immunostimulatory Toll-like receptor 9 agonist oligodeoxynucleotide CpG 7909 in a 0.5 mL phosphate-buffered suspension. General toxicity and local reactogenicity were evaluated in Sprague Dawley rats vaccinated with the full human dose of rPA7909 by intramuscular injection. Animals were immunized on study days 1, 15, and 29. Control groups were administered diluent only or adjuvant control (excipients, CpG 7909, and Alhydrogel adjuvant in diluent) intramuscularly at the same dose volume and according to the same schedule used for rPA7909. Toxicity was assessed based on the results of clinical observations, physical examinations, body weights, injection site reactogenicity, ophthalmology, clinical pathology (hematology, coagulation, and serum chemistry), organ weights, and macroscopic and microscopic pathology evaluation. The immune response to rPA7909 vaccination was confirmed by measuring serum anti-PA immunoglobulin G levels. The rPA7909 vaccine produced no apparent systemic toxicity and only transient reactogenicity at the injection site. The injection site reaction from animals receiving the adjuvant control was very similar to those receiving rPA7909 with respect to the inflammation. The inflammatory response observed in the injection site and the draining lymph nodes was consistent with expected immune stimulation. The overall results indicated a favorable safety profile for rPA7909.<\/jats:p>","DOI":"10.1177\/1091581819848722","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T01:50:28Z","timestamp":1560131428000},"page":"163-172","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Repeat-Dose Toxicity Study of a Lyophilized Recombinant Protective Antigen-Based Anthrax Vaccine Adjuvanted With CpG 7909"],"prefix":"10.1177","volume":"38","author":[{"given":"Vladimir","family":"Savransky","sequence":"first","affiliation":[{"name":"Emergent BioSolutions Inc, Gaithersburg, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lacy","sequence":"additional","affiliation":[{"name":"Emergent BioSolutions Inc, Gaithersburg, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Ionin","sequence":"additional","affiliation":[{"name":"Emergent BioSolutions Inc, Gaithersburg, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario H.","family":"Skiadopoulos","sequence":"additional","affiliation":[{"name":"Emergent BioSolutions Inc, Gaithersburg, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3528-3544","authenticated-orcid":false,"given":"Jeffry","family":"Shearer","sequence":"additional","affiliation":[{"name":"Emergent BioSolutions Inc, Gaithersburg, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2019,6,9]]},"reference":[{"key":"bibr1-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-micro-091014-104523"},{"key":"bibr2-1091581819848722","first-page":"335","volume":"20","author":"Friedlander AM","year":"2000","journal-title":"Curr Clin Top Infect Dis"},{"key":"bibr3-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1007\/s10254-004-0028-2"},{"key":"bibr4-1091581819848722","doi-asserted-by":"publisher","DOI":"10.3201\/eid2007.131764"},{"key":"bibr5-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1980.tb18910.x"},{"key":"bibr6-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.5.429"},{"key":"bibr7-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1038\/430843a"},{"key":"bibr8-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-0101(01)00161-1"},{"key":"bibr9-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2068"},{"key":"bibr10-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8627(02)00005-6"},{"key":"bibr11-1091581819848722","unstructured":"Federal Select Agent Program. Select Agents and Toxins List. https:\/\/www.selectagents.gov\/SelectAgentsandToxins.html."},{"key":"bibr12-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1586\/erv.10.174"},{"key":"bibr13-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2007.04.003"},{"key":"bibr14-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.26.15553"},{"key":"bibr15-1091581819848722","doi-asserted-by":"publisher","DOI":"10.2165\/00126839-200607050-00004"},{"key":"bibr16-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.07.076"},{"key":"bibr17-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.05.047"},{"key":"bibr18-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.04.063"},{"key":"bibr19-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.03.006"},{"key":"bibr20-1091581819848722","volume-title":"WHO Guidelines on Nonclinical Evaluation of Vaccines. WHO Technical Report Series","author":"World Health Organization","year":"2013"},{"key":"bibr21-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60761-585-9_3"},{"key":"bibr22-1091581819848722","volume-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council","year":"1996","edition":"7"},{"key":"bibr23-1091581819848722","unstructured":"Draize JH. Appraisal of the Safety of Chemicals in Foods, Drugs and Cosmetics. Austin, TX: Editorial Committee of the Association of Food and Drug Officials of the United States, Bureau of Food and Drugs; 1959:46\u201359."},{"key":"bibr24-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.12.034"},{"key":"bibr25-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2004.12.013"},{"key":"bibr26-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1002\/jat.3314"},{"issue":"6","key":"bibr27-1091581819848722","first-page":"517","volume":"59","author":"Cray C","year":"2009","journal-title":"Comp Med"},{"key":"bibr28-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-003-0458-7"},{"key":"bibr29-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1002\/jat.3025"},{"key":"bibr30-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(93)90190-9"},{"key":"bibr31-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1006\/biol.1994.1008"},{"key":"bibr32-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022271"},{"key":"bibr33-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002940"},{"key":"bibr34-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.08.023"},{"key":"bibr35-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000183514.37513.d2"},{"key":"bibr36-1091581819848722","doi-asserted-by":"publisher","DOI":"10.4161\/hv.20707"},{"key":"bibr37-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1086\/653112"},{"key":"bibr38-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.01.058"},{"key":"bibr39-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis107"},{"key":"bibr40-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.06.065"},{"key":"bibr41-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1177\/1091581813497405"},{"key":"bibr42-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.035"},{"key":"bibr43-1091581819848722","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.4.6.855"}],"container-title":["International Journal of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1091581819848722","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1091581819848722","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1091581819848722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:21:40Z","timestamp":1777458100000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1091581819848722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1177\/1091581819848722"],"URL":"https:\/\/doi.org\/10.1177\/1091581819848722","relation":{},"ISSN":["1091-5818","1092-874X"],"issn-type":[{"value":"1091-5818","type":"print"},{"value":"1092-874X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}